Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Fibrosis (IPF)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00005317
What this trial is testing

Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases

Who this might be right for
Lung DiseasesPulmonary FibrosisLung Diseases, Interstitial+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT05185089
What this trial is testing

Efficacy and Safety Study of Orvepitant for Chronic Cough in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
CoughIdiopathic Pulmonary Fibrosis
Nerre Therapeutics Ltd. 80
Not applicableUnknownNCT05450276
What this trial is testing

Patient-Reported Outcome Study of Project ECHO for ILD

Who this might be right for
Interstitial Lung Disease
Pulmonary Care and Research Collaborative Limited 56
Early research (Phase 1)Study completedNCT05657184
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND001

Who this might be right for
Idiopathic Pulmonary Fibrosis
Regend Therapeutics 12
Testing effectiveness (Phase 2)Ended earlyNCT02138825
What this trial is testing

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

Who this might be right for
Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Bayer 147
Not applicableStudy completedNCT02437448
What this trial is testing

Breath Analysis in Lung Fibrosis

Who this might be right for
Idiopathic Lung FibrosisIdiopathic Pulmonary Fibrosis
University of Zurich 31
Not applicableStudy completedNCT04803617
What this trial is testing

Investigation of Pectoralis Muscle Strength in Elderly With Interstitial Lung Disease

Who this might be right for
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisSarcoidosis, Pulmonary+1 more
Habibedurdu 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT06588686
What this trial is testing

A Trial to Evaluate Efficacy and Safety of Buloxibutid in People With Idiopathic Pulmonary Fibrosis.

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Vicore Pharma AB 378
Testing effectiveness (Phase 2)Looking for participantsNCT07516951
What this trial is testing

Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Chiesi Farmaceutici S.p.A. 240
Not applicableStudy completedNCT03078426
What this trial is testing

Lung MRI in the Management of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University Hospital, Bordeaux 60
Testing effectiveness (Phase 2)Study completedNCT05938920
What this trial is testing

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
InSilico Medicine Hong Kong Limited 71
Post-approval studies (Phase 4)WithdrawnNCT00625079
What this trial is testing

Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary FibrosisInterstitial Lung Disease+1 more
University of California, Los Angeles
Not applicableStudy completedNCT04187079
What this trial is testing

Immunopathologic Profiles and Blood Biomarkers in Patients With IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Aarhus 100
Not applicableActive Not RecruitingNCT03041623
What this trial is testing

Japanese Idiopathic Interstitial Pneumonias Registry

Who this might be right for
Idiopathic Interstitial Pneumonia
North East Japan Study Group 867
Large-scale testing (Phase 3)Looking for participantsNCT05674994
What this trial is testing

Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Who this might be right for
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Fondation Hôpital Saint-Joseph 110
Not applicableLooking for participantsNCT07373288
What this trial is testing

HOXB7 and Linked Tissue and Blood Biomarkers in the Lungs of Patients With Pulmonary Fibrosis

Who this might be right for
Fibrosis, Pulmonary
University of Modena and Reggio Emilia 80
Not applicableStudy completedNCT03979703
What this trial is testing

Yoga in Patients With Fibrosing Interstitial Lung Diseases

Who this might be right for
Fibrosing Interstitial Lung DiseasesIdiopathic Pulmonary Fibrosis
Heidelberg University 17
Early research (Phase 1)Study completedNCT05134727
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 Following Single and Multiple Ascending Doses in Healthy Participants

Who this might be right for
Idiopathic Pulmonary Fibrosis
AstraZeneca 63
Early research (Phase 1)Study completedNCT05895565
What this trial is testing

A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects

Who this might be right for
IPF
Pulmongene Ltd. 29
Very early researchNot Yet RecruitingNCT07359963
What this trial is testing

Treatment of Idiopathic Pulmonary Fibrosis (IPF) by REGEND007 Cell Therapy

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Regend Therapeutics 12
Next Page